FORMOTEROL FUMARATE

FORMOTEROL FUMARATE was reported 97871 times

FORMOTEROL FUMARATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CFTR GENE MUTATION 15 0.6000
1 HYPER IGE SYNDROME 44 0.3860
2 SALPINGO-OOPHORECTOMY UNILATERAL 36 0.3273
3 TOTAL LUNG CAPACITY ABNORMAL 84 0.2159
4 SPUTUM CULTURE 7 0.1892
5 SPIROMETRY ABNORMAL 113 0.1890
6 PULMONARY VASCULITIS 101 0.1877
7 COCKROACH ALLERGY 9 0.1875
8 CAPILLARITIS 51 0.1848
9 OPTIC NERVE OPERATION 4 0.1600
10 MITE ALLERGY 98 0.1496
11 EJECTION FRACTION 82 0.1411
12 VASCULAR GRAFT INFECTION 6 0.1364
13 ARTHRITIS ALLERGIC 3 0.1250
14 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 63 0.1205
15 SENSITISATION 91 0.1199
16 MYCOTIC ALLERGY 102 0.1193
17 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 107 0.1154
18 DUST ALLERGY 111 0.1131
19 ACQUIRED FACTOR V DEFICIENCY 11 0.1000
20 NEUROSENSORY HYPOACUSIS 12 0.0992
21 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 72 0.0982
22 EOSINOPHIL COUNT 11 0.0948
23 COAGULATION FACTOR V LEVEL ABNORMAL 11 0.0894
24 POLYCYSTIC OVARIES 134 0.0863
25 ALVEOLAR OSTEITIS 35 0.0827
26 EOSINOPHILIC BRONCHITIS 16 0.0800
27 URINARY TRACT DISCOMFORT 35 0.0759
28 COAGULATION FACTOR DEFICIENCY 11 0.0683
29 CONJUNCTIVITIS ALLERGIC 101 0.0682
30 INTESTINAL ATONY 4 0.0656
31 ATYPICAL MIGRAINE 3 0.0652
32 RIGHT ATRIAL HYPERTROPHY 7 0.0636
33 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 123 0.0603
34 NEURITIS 90 0.0583
35 SINUSITIS FUNGAL 43 0.0536
36 RESPIRATORY SYMPTOM 148 0.0520
37 LUNG DIFFUSION TEST ABNORMAL 5 0.0515
38 VITAL CAPACITY DECREASED 22 0.0491
39 TOTAL LUNG CAPACITY INCREASED 13 0.0478
40 CONGENITAL HIATUS HERNIA 10 0.0439
41 PRESBYACUSIS 13 0.0422
42 RESTRICTIVE PULMONARY DISEASE 49 0.0418
43 FORCED EXPIRATORY VOLUME ABNORMAL 6 0.0414
44 REVERSIBLE AIRWAYS OBSTRUCTION 21 0.0413
45 EJECTION FRACTION ABNORMAL 49 0.0400
46 B-LYMPHOCYTE COUNT ABNORMAL 4 0.0396
47 EYE PARAESTHESIA 6 0.0382
48 OBSTRUCTIVE AIRWAYS DISORDER 424 0.0381
49 FORCED EXPIRATORY VOLUME DECREASED 105 0.0370
50 ANIMAL SCRATCH 35 0.0360
51 OBSTRUCTIVE SLEEP APNOEA SYNDROME 52 0.0356
52 PNEUMOCOCCAL INFECTION 21 0.0355
53 TOTAL LUNG CAPACITY DECREASED 55 0.0344
54 SINUS PAIN 77 0.0330
55 BALANITIS 4 0.0328
56 NORMOCHROMIC NORMOCYTIC ANAEMIA 97 0.0323
57 NEPHRECTOMY 47 0.0316
58 FULL BLOOD COUNT ABNORMAL 328 0.0310
59 PANCREATIC CALCIFICATION 4 0.0308
60 FACTOR V LEIDEN MUTATION 12 0.0302
61 LUNG OPACITY 79 0.0299
62 BRONCHIECTASIS 191 0.0283
63 VACCINATION SITE PAIN 16 0.0278
64 ALLERGIC BRONCHITIS 3 0.0270
65 SPUTUM INCREASED 58 0.0268
66 SPUTUM CULTURE POSITIVE 21 0.0259
67 FEMALE GENITAL TRACT FISTULA 44 0.0257
68 BLOOD ALKALINE PHOSPHATASE ABNORMAL 23 0.0256
69 NASAL MUCOSAL DISCOLOURATION 4 0.0248
70 ALLERGIC GRANULOMATOUS ANGIITIS 20 0.0244
71 RHINITIS ALLERGIC 105 0.0236
72 NASAL POLYPS 115 0.0233
73 PHARYNGITIS BACTERIAL 6 0.0233
74 FRACTIONAL EXHALED NITRIC OXIDE INCREASED 4 0.0223
75 BRONCHIAL SECRETION RETENTION 28 0.0220
76 NASAL OBSTRUCTION 40 0.0213
77 LIPOHYPERTROPHY 13 0.0209
78 POLYCYSTIC OVARIAN SYNDROME 8 0.0208
79 PLEURITIC PAIN 57 0.0206
80 VOCAL CORD DYSFUNCTION 10 0.0203
81 PERINEAL INFECTION 4 0.0202
82 ENTEROBIASIS 3 0.0201
83 SPUTUM DISCOLOURED 191 0.0201
84 HUMIDITY INTOLERANCE 8 0.0200
85 BRONCHIAL OBSTRUCTION 27 0.0192
86 SCROTAL INFECTION 4 0.0190
87 RALES 109 0.0188
88 TUNNEL VISION 35 0.0187
89 VACCINATION SITE ERYTHEMA 4 0.0185
90 PANCREATITIS RELAPSING 15 0.0183
91 CHRONIC SINUSITIS 68 0.0181
92 LIP PRURITUS 15 0.0175
93 ALLERGIC SINUSITIS 15 0.0175
94 UROGENITAL FISTULA 4 0.0169
95 MYCOBACTERIUM AVIUM COMPLEX INFECTION 45 0.0167
96 BRONCHIAL HYPERREACTIVITY 20 0.0166
97 DIASTOLIC DYSFUNCTION 51 0.0165
98 PULMONARY ALVEOLAR HAEMORRHAGE 92 0.0164
99 PULMONARY FUNCTION TEST ABNORMAL 25 0.0160
100 BENIGN LUNG NEOPLASM 4 0.0158
101 LUNG CONSOLIDATION 44 0.0157
102 VASCULAR GRAFT OCCLUSION 6 0.0156
103 INJECTION SITE ECZEMA 3 0.0156
104 NEUROLOGICAL SYMPTOM 89 0.0156
105 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 261 0.0154
106 ARTERIOSCLEROSIS CORONARY ARTERY 96 0.0145
107 PARANASAL SINUS DISCOMFORT 54 0.0143
108 EMBOLISM VENOUS 43 0.0142
109 BLOOD TEST ABNORMAL 197 0.0140
110 INCREASED BRONCHIAL SECRETION 35 0.0137
111 EMPHYSEMA 138 0.0137
112 EAR CONGESTION 37 0.0136
113 PULMONARY FUNCTION TEST DECREASED 59 0.0135
114 BRONCHOSPASM PARADOXICAL 4 0.0133
115 OPPOSITIONAL DEFIANT DISORDER 5 0.0127
116 BREAST NEOPLASM 13 0.0126
117 BONE DENSITY INCREASED 5 0.0125
118 BRONCHIAL WALL THICKENING 9 0.0125
119 EOSINOPHIL COUNT INCREASED 96 0.0115
120 VASCULITIS 134 0.0115
121 ALANINE AMINOTRANSFERASE ABNORMAL 24 0.0114
122 POLYMYALGIA RHEUMATICA 36 0.0113
123 INFECTED DERMAL CYST 4 0.0111
124 BLADDER PAIN 35 0.0110
125 LUNG INFECTION PSEUDOMONAL 6 0.0108
126 SLEEP APNOEA SYNDROME 203 0.0106
127 MACROCYTOSIS 12 0.0103
128 WOUND COMPLICATION 35 0.0102
129 ARTERIOSCLEROSIS 95 0.0101
130 WHEEZING 580 0.0098
131 ASTHMA 1095 0.0097
132 DRY GANGRENE 6 0.0094
133 DYSLIPIDAEMIA 48 0.0094
134 WOUND SECRETION 37 0.0094
135 MYOCLONIC EPILEPSY 14 0.0092
136 PULMONARY MASS 134 0.0090
137 BREATH SOUNDS ABNORMAL 44 0.0089
138 EFFUSION 12 0.0088
139 ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED 3 0.0088
140 ARTHROSCOPY 6 0.0087
141 ANGIOPLASTY 13 0.0087
142 BLOOD IMMUNOGLOBULIN E INCREASED 21 0.0087
143 MENINGISM 4 0.0085
144 SARS-COV-2 ANTIBODY TEST NEGATIVE 4 0.0084
145 PULMONARY FIBROSIS 159 0.0083
146 ARTERIOVENOUS FISTULA 4 0.0081
147 BLADDER DISCOMFORT 10 0.0080
148 EOSINOPHIL COUNT DECREASED 19 0.0080
149 KYPHOSIS 14 0.0079
150 CALCULUS URINARY 12 0.0078
151 RIGHT VENTRICULAR HYPERTROPHY 7 0.0078
152 NODULE 101 0.0077
153 BODY FAT DISORDER 4 0.0074
154 ENDOMETRIAL THICKENING 4 0.0072
155 HAEMOPTYSIS 199 0.0071
156 FUNGAL OESOPHAGITIS 5 0.0071
157 PERFUME SENSITIVITY 4 0.0070
158 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 45 0.0069
159 HYPOTHYROIDISM 220 0.0069
160 BLOOD CALCIUM INCREASED 59 0.0067
161 UPPER RESPIRATORY TRACT INFLAMMATION 8 0.0067
162 NASAL INFLAMMATION 7 0.0066
163 LIPOMA 17 0.0066
164 BRONCHITIS CHRONIC 16 0.0065
165 CARPAL TUNNEL SYNDROME 91 0.0065
166 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 457 0.0064
167 MULTIPLE ALLERGIES 50 0.0064
168 TOXIC SHOCK SYNDROME 4 0.0063
169 UTERINE ENLARGEMENT 5 0.0063
170 ANAL INFLAMMATION 4 0.0063
171 HEAT EXHAUSTION 5 0.0062
172 DIVERTICULUM 44 0.0062
173 SENSE OF OPPRESSION 7 0.0059
174 ADRENAL SUPPRESSION 5 0.0059
175 HYPOCHROMIC ANAEMIA 6 0.0059
176 ASPIRATION 64 0.0058
177 GRANULOMATOSIS WITH POLYANGIITIS 7 0.0058
178 NASAL DISCHARGE DISCOLOURATION 8 0.0058
179 CUSHING'S SYNDROME 4 0.0058
180 PRODUCTIVE COUGH 273 0.0057
181 TRICUSPID VALVE INCOMPETENCE 45 0.0057
182 RHINITIS 45 0.0056
183 BODY TEMPERATURE ABNORMAL 10 0.0054
184 IRON DEFICIENCY ANAEMIA 50 0.0054
185 CREPITATIONS 16 0.0054
186 RUBBER SENSITIVITY 8 0.0052
187 CYSTITIS NONINFECTIVE 7 0.0052
188 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 249 0.0052
189 STRIDOR 15 0.0051
190 AORTIC VALVE STENOSIS 9 0.0050
191 UPPER-AIRWAY COUGH SYNDROME 41 0.0050
192 ARTHRITIS REACTIVE 3 0.0048
193 GASTROOESOPHAGEAL REFLUX DISEASE 386 0.0048
194 HYPOXIA 167 0.0047
195 ASTHMATIC CRISIS 17 0.0046
196 SENSITIVITY TO WEATHER CHANGE 24 0.0046
197 THROAT CLEARING 17 0.0045
198 NEPHROPATHY 42 0.0045
199 SUFFOCATION FEELING 11 0.0044
200 B-LYMPHOCYTE COUNT DECREASED 6 0.0044
201 METABOLIC SURGERY 5 0.0044
202 CUSHINGOID 14 0.0044
203 HYSTERECTOMY 37 0.0043
204 HIATUS HERNIA 53 0.0041
205 MYOPATHY 35 0.0040
206 EOSINOPHIL COUNT ABNORMAL 3 0.0040
207 SARCOIDOSIS 19 0.0040
208 TERMINAL INSOMNIA 7 0.0040
209 ISCHAEMIC CARDIOMYOPATHY 12 0.0039
210 FIBROMYALGIA 95 0.0039
211 ALLERGY TO ANIMAL 4 0.0038
212 SCLERITIS 6 0.0037
213 CARBON DIOXIDE INCREASED 5 0.0037
214 LOWER RESPIRATORY TRACT INFECTION 165 0.0036
215 BLOOD PRESSURE DIASTOLIC ABNORMAL 9 0.0035
216 PULMONARY GRANULOMA 4 0.0035
217 SKIN LACERATION 38 0.0035
218 BENIGN PROSTATIC HYPERPLASIA 18 0.0035
219 FOLATE DEFICIENCY 4 0.0035
220 SEBORRHOEIC KERATOSIS 5 0.0034
221 PULMONARY PAIN 10 0.0034
222 PNEUMONIA INFLUENZAL 4 0.0034
223 OROPHARYNGEAL CANDIDIASIS 3 0.0033
224 CHRONIC RESPIRATORY FAILURE 4 0.0033
225 HYPERVENTILATION 19 0.0033
226 PNEUMONIA PSEUDOMONAL 5 0.0033
227 INAPPROPRIATE AFFECT 5 0.0032
228 CANDIDA INFECTION 53 0.0031
229 SINUS DISORDER 62 0.0031
230 BLOOD PRESSURE SYSTOLIC INCREASED 61 0.0031
231 BLOOD IRON DECREASED 37 0.0031
232 COMPUTERISED TOMOGRAM ABNORMAL 7 0.0031
233 BODY TEMPERATURE DECREASED 30 0.0030
234 ABSCESS 48 0.0030
235 RESPIRATORY TRACT INFECTION VIRAL 7 0.0030
236 EOSINOPHILIA 52 0.0030
237 VULVOVAGINAL CANDIDIASIS 4 0.0030
238 CHEST X-RAY ABNORMAL 9 0.0029
239 PERIPHERAL VASCULAR DISORDER 15 0.0029
240 RESPIRATORY DISORDER 87 0.0029
241 PAINFUL RESPIRATION 7 0.0029
242 BONE MARROW OEDEMA 3 0.0029
243 SKIN INDURATION 6 0.0029
244 HANGOVER 10 0.0028
245 OSTEOPENIA 43 0.0028
246 NEUTROPHILIA 16 0.0028
247 LIVER FUNCTION TEST INCREASED 60 0.0028
248 LUNG DISORDER 136 0.0028
249 HYPOVENTILATION 9 0.0028
250 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 143 0.0027
251 PULMONARY CONGESTION 36 0.0027
252 SINUS NODE DYSFUNCTION 5 0.0027
253 HYPOAESTHESIA ORAL 41 0.0027
254 TRANSAMINASES INCREASED 60 0.0027
255 HYPOKINESIA 39 0.0027
256 CORNEAL OEDEMA 6 0.0027
257 SYMPTOM RECURRENCE 16 0.0027
258 TYPE 2 DIABETES MELLITUS 90 0.0027
259 UPPER RESPIRATORY TRACT INFECTION 123 0.0027
260 SKIN LESION 73 0.0027
261 RESPIRATORY TRACT INFECTION 69 0.0026
262 RESTLESS LEGS SYNDROME 48 0.0026
263 DYSPNOEA EXERTIONAL 99 0.0026
264 POLYP 17 0.0026
265 BRONCHIAL DISORDER 4 0.0026
266 EAR PAIN 49 0.0025
267 FOREIGN BODY SENSATION IN EYES 16 0.0025
268 OBSTRUCTION 10 0.0025
269 PARADOXICAL DRUG REACTION 9 0.0024
270 LIMB INJURY 66 0.0024
271 SPINAL STENOSIS 10 0.0024
272 CORONARY ARTERY DISEASE 73 0.0024
273 JOINT INJURY 51 0.0024
274 BLOOD COUNT ABNORMAL 36 0.0024
275 URINARY TRACT INFECTION BACTERIAL 6 0.0024
276 MALLORY-WEISS SYNDROME 3 0.0024
277 MICROCEPHALY 3 0.0023
278 INFARCTION 16 0.0023
279 COUGH 641 0.0023
280 NOSOCOMIAL INFECTION 5 0.0023
281 JAUNDICE CHOLESTATIC 8 0.0023
282 CALCINOSIS 5 0.0022
283 POST-TRAUMATIC STRESS DISORDER 15 0.0022
284 ECZEMA 117 0.0022
285 PSEUDOMONAS INFECTION 19 0.0022
286 CHRONIC GASTRITIS 5 0.0022
287 OSTEOPOROSIS 91 0.0022
288 VENOUS OCCLUSION 4 0.0022
289 CALCULUS BLADDER 3 0.0022
290 APHTHOUS ULCER 17 0.0022
291 HYPOMANIA 8 0.0022
292 HEPATIC NEOPLASM 7 0.0021
293 NASAL CONGESTION 126 0.0021
294 ANAL HAEMORRHAGE 6 0.0021
295 ATRIAL FLUTTER 17 0.0021
296 LUNG NEOPLASM 9 0.0021
297 CHEST DISCOMFORT 215 0.0021
298 SINUS CONGESTION 28 0.0021
299 CONCUSSION 16 0.0021
300 BLOOD URINE PRESENT 39 0.0021
301 DERMAL CYST 5 0.0020
302 BLOOD PRESSURE SYSTOLIC ABNORMAL 5 0.0020
303 DISABILITY 40 0.0020
304 DISEASE RECURRENCE 96 0.0020
305 DYSPNOEA 1128 0.0020
306 PROCEDURAL PAIN 55 0.0020
307 ORAL CANDIDIASIS 26 0.0020
308 EYELID PTOSIS 20 0.0020
309 BODY TEMPERATURE INCREASED 40 0.0020
310 RENAL DISORDER 91 0.0020
311 BURNING SENSATION 136 0.0019
312 PULMONARY EMBOLISM 180 0.0019
313 VASCULAR OCCLUSION 4 0.0019
314 BRONCHOSPASM 27 0.0019
315 RESPIRATORY TRACT CONGESTION 30 0.0019
316 POOR PERIPHERAL CIRCULATION 8 0.0019
317 MIDDLE INSOMNIA 35 0.0019
318 OEDEMA 101 0.0019
319 DEMENTIA ALZHEIMER'S TYPE 3 0.0018
320 BRONCHITIS 133 0.0018
321 HYPERCHOLESTEROLAEMIA 17 0.0018
322 REGURGITATION 6 0.0017
323 CARDIAC MURMUR 15 0.0017
324 LICHEN PLANUS 4 0.0017
325 PERFORMANCE STATUS DECREASED 8 0.0017
326 UMBILICAL HERNIA 8 0.0017
327 LUMBAR SPINAL STENOSIS 5 0.0017
328 OVERWEIGHT 9 0.0017
329 APPARENT DEATH 6 0.0017
330 NASAL OEDEMA 3 0.0017
331 HYPERCAPNIA 5 0.0017
332 NORMAL NEWBORN 9 0.0017
333 THROMBOSIS 131 0.0016
334 THROAT IRRITATION 73 0.0016
335 HYPERTENSIVE CRISIS 18 0.0016
336 WOUND 45 0.0016
337 FUNGAL INFECTION 53 0.0016
338 FEELING COLD 44 0.0016
339 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 8 0.0016
340 PARKINSON'S DISEASE 4 0.0016
341 OEDEMA PERIPHERAL 189 0.0015
342 VULVOVAGINAL DRYNESS 5 0.0015
343 CONCOMITANT DISEASE PROGRESSION 3 0.0015
344 RHINORRHOEA 99 0.0015
345 CARDIAC DISORDER 142 0.0015
346 SECRETION DISCHARGE 19 0.0015
347 HYPERLACTACIDAEMIA 4 0.0015
348 OESOPHAGITIS 16 0.0015
349 BRONCHOPNEUMONIA 5 0.0015
350 ESCHERICHIA INFECTION 12 0.0015
351 CONJUNCTIVITIS 27 0.0015
352 SINUSITIS 149 0.0015
353 TENOSYNOVITIS 4 0.0014
354 HYPERTENSION 304 0.0014
355 ATRIAL TACHYCARDIA 3 0.0014
356 HYPERVOLAEMIA 7 0.0014
357 SEASONAL ALLERGY 20 0.0014
358 DYSURIA 52 0.0014
359 THERAPY PARTIAL RESPONDER 22 0.0014
360 OROPHARYNGEAL PAIN 130 0.0014
361 BRAIN INJURY 14 0.0014
362 EXERCISE TOLERANCE DECREASED 8 0.0014
363 PANIC REACTION 10 0.0014
364 PYELONEPHRITIS 12 0.0014
365 SNEEZING 31 0.0014
366 OESOPHAGEAL VARICES HAEMORRHAGE 3 0.0014
367 TOOTH INJURY 6 0.0014
368 DYSPNOEA AT REST 4 0.0014
369 RESPIRATORY SYNCYTIAL VIRUS INFECTION 12 0.0014
370 HYPOACUSIS 59 0.0014
371 INCREASED UPPER AIRWAY SECRETION 7 0.0014
372 COLONOSCOPY 3 0.0014
373 FRUSTRATION TOLERANCE DECREASED 11 0.0014
374 WRIST FRACTURE 16 0.0013
375 BLOOD PRESSURE FLUCTUATION 32 0.0013
376 PARALYSIS 19 0.0013
377 PNEUMONIA 428 0.0013
378 RESPIRATION ABNORMAL 9 0.0013
379 ACUTE RESPIRATORY FAILURE 25 0.0013
380 FOOD ALLERGY 10 0.0013
381 PANIC ATTACK 47 0.0013
382 BACTERIAL INFECTION 24 0.0013
383 MOVEMENT DISORDER 41 0.0013
384 EYE HAEMORRHAGE 17 0.0013
385 INFUSION SITE PRURITUS 4 0.0013
386 PNEUMONIA FUNGAL 5 0.0013
387 URINARY RETENTION 42 0.0013
388 MUSCLE DISORDER 10 0.0012
389 CHOKING 24 0.0012
390 HAEMATOLOGICAL INFECTION 3 0.0012
391 BLOOD PRESSURE DIASTOLIC DECREASED 9 0.0012
392 APHONIA 17 0.0012
393 LISTLESS 4 0.0012
394 LIGAMENT SPRAIN 12 0.0012
395 SOCIAL PROBLEM 5 0.0012
396 OSTEOARTHRITIS 51 0.0012
397 CATHETER SITE HAEMORRHAGE 3 0.0012
398 CEREBRAL ISCHAEMIA 6 0.0012
399 BLOOD CREATININE INCREASED 76 0.0012
400 CONGENITAL ANOMALY 9 0.0012
401 LEFT VENTRICULAR FAILURE 4 0.0012
402 LUNG INFECTION 18 0.0012
403 APNOEA 9 0.0012
404 POLLAKIURIA 48 0.0011
405 GLAUCOMA 22 0.0011
406 HAEMATURIA 39 0.0011
407 ANIMAL BITE 3 0.0011
408 ANAL FISTULA 6 0.0011
409 AREFLEXIA 3 0.0011
410 HAEMORRHAGIC DIATHESIS 4 0.0011
411 LARYNGOSPASM 3 0.0011
412 GOUT 20 0.0011
413 OXYGEN SATURATION DECREASED 62 0.0011
414 TRANSIENT ISCHAEMIC ATTACK 37 0.0011
415 SLEEP DISORDER 77 0.0011
416 HYPERGLYCAEMIA 39 0.0011
417 NEPHROLITHIASIS 49 0.0011
418 PLEURAL EFFUSION 65 0.0011
419 INFLUENZA 119 0.0011
420 PERIORBITAL SWELLING 6 0.0011
421 OXYGEN SATURATION ABNORMAL 3 0.0011
422 TENDON PAIN 8 0.0011
423 SINUS TACHYCARDIA 15 0.0011
424 ESCHERICHIA SEPSIS 3 0.0010
425 CERVIX CARCINOMA 4 0.0010
426 CARDIOMYOPATHY 15 0.0010
427 CELLULITIS 51 0.0010
428 DYSARTHRIA 38 0.0010
429 IMMUNODEFICIENCY 15 0.0010
430 EXTRASYSTOLES 7 0.0010
431 CANDIDIASIS 4 0.0010
432 INTRACRANIAL ANEURYSM 4 0.0010
433 INJECTION SITE VESICLES 6 0.0010
434 ACUTE MYOCARDIAL INFARCTION 29 0.0010
435 BLOOD BLISTER 3 0.0010
436 HEART RATE INCREASED 95 0.0010
437 NASAL DRYNESS 6 0.0010
438 ORAL DISORDER 7 0.0010
439 CARDIAC FAILURE 76 0.0009
440 DYSPHONIA 55 0.0009
441 AORTIC VALVE INCOMPETENCE 4 0.0009
442 STRESS FRACTURE 5 0.0009
443 BEHAVIOUR DISORDER 5 0.0009
444 CHOKING SENSATION 5 0.0009
445 LIGAMENT RUPTURE 4 0.0009
446 DIABETES MELLITUS 69 0.0009
447 LOW DENSITY LIPOPROTEIN INCREASED 7 0.0009
448 SALIVARY HYPERSECRETION 9 0.0009
449 OROPHARYNGEAL DISCOMFORT 8 0.0009
450 TOOTH ABSCESS 9 0.0009
451 BLOOD PRESSURE INCREASED 135 0.0009
452 PALLOR 24 0.0009
453 BLISTER 49 0.0009
454 ISCHAEMIA 4 0.0009
455 SYNCOPE 87 0.0009
456 INTERVERTEBRAL DISC DEGENERATION 8 0.0009
457 POST PROCEDURAL INFECTION 7 0.0009
458 GASTRITIS EROSIVE 4 0.0009
459 SKIN ABRASION 4 0.0008
460 ACCIDENT 10 0.0008
461 BASAL CELL CARCINOMA 13 0.0008
462 LACRIMATION INCREASED 25 0.0008
463 MONOCYTE COUNT INCREASED 3 0.0008
464 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 5 0.0008
465 HOSPITALISATION 126 0.0008
466 MYOCARDIAL INFARCTION 143 0.0008
467 VITAMIN D DECREASED 7 0.0008
468 LARYNGEAL OEDEMA 5 0.0008
469 MUSCULOSKELETAL STIFFNESS 71 0.0008
470 CONCOMITANT DISEASE AGGRAVATED 5 0.0008
471 EXPIRED DRUG ADMINISTERED 4 0.0008
472 DEEP VEIN THROMBOSIS 52 0.0008
473 REBOUND EFFECT 9 0.0008
474 EAR INFECTION 21 0.0008
475 ILLNESS 81 0.0008
476 GINGIVAL DISORDER 3 0.0008
477 OESOPHAGEAL ULCER 3 0.0008
478 INITIAL INSOMNIA 8 0.0008
479 ANAL INCONTINENCE 7 0.0008
480 URINARY INCONTINENCE 23 0.0008
481 BRONCHOPULMONARY ASPERGILLOSIS 6 0.0008
482 INJECTION SITE DISCOMFORT 8 0.0008
483 BLOOD LACTIC ACID INCREASED 4 0.0008
484 SKIN EXFOLIATION 64 0.0008
485 DYSSTASIA 22 0.0008
486 OBESITY 12 0.0008
487 MULTI-ORGAN FAILURE 13 0.0008
488 CARDIAC FAILURE ACUTE 5 0.0007
489 QUALITY OF LIFE DECREASED 10 0.0007
490 ANXIETY 211 0.0007
491 SPINAL DISORDER 7 0.0007
492 TACHYPNOEA 10 0.0007
493 ASPHYXIA 6 0.0007
494 ECCHYMOSIS 5 0.0007
495 TOOTH FRACTURE 8 0.0007
496 ATELECTASIS 7 0.0007
497 CONDITION AGGRAVATED 220 0.0007
498 PAIN IN EXTREMITY 213 0.0007
499 INTRACRANIAL PRESSURE INCREASED 4 0.0007
500 ROAD TRAFFIC ACCIDENT 30 0.0007
501 PULMONARY OEDEMA 32 0.0007
502 ANGIOPATHY 4 0.0007
503 CHEST PAIN 132 0.0007
504 HEART RATE DECREASED 25 0.0007
505 INFUSION SITE ERYTHEMA 6 0.0007
506 LUNG NEOPLASM MALIGNANT 29 0.0007
507 SKIN ATROPHY 4 0.0007
508 ELECTROCARDIOGRAM QT PROLONGED 25 0.0007
509 WEIGHT INCREASED 155 0.0007
510 ANAPHYLACTIC REACTION 38 0.0007
511 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 7 0.0007
512 URINE ODOUR ABNORMAL 4 0.0007
513 HYPERCHLORHYDRIA 4 0.0007
514 RESPIRATORY RATE INCREASED 6 0.0007
515 RESPIRATORY FAILURE 49 0.0007
516 INFLUENZA LIKE ILLNESS 55 0.0007
517 RENAL PAIN 7 0.0007
518 CLOSTRIDIUM DIFFICILE COLITIS 7 0.0007
519 SCHIZOPHRENIA 8 0.0007
520 IMMUNE THROMBOCYTOPENIA 3 0.0007
521 BALANCE DISORDER 56 0.0006
522 LIMB DISCOMFORT 20 0.0006
523 DEPRESSION 147 0.0006
524 NASOPHARYNGITIS 119 0.0006
525 TOOTH EXTRACTION 8 0.0006
526 INFUSION SITE EXTRAVASATION 4 0.0006
527 INFUSION SITE SWELLING 4 0.0006
528 FRACTURE 12 0.0006
529 PARAESTHESIA 99 0.0006
530 HEPATOTOXICITY 14 0.0006
531 GASTROENTERITIS 9 0.0006
532 GENERAL PHYSICAL HEALTH DETERIORATION 71 0.0006
533 PLATELET COUNT INCREASED 8 0.0006
534 MICTURITION URGENCY 7 0.0006
535 REFUSAL OF TREATMENT BY PATIENT 4 0.0006
536 TACHYCARDIA 54 0.0006
537 ADVERSE EVENT 56 0.0006
538 PYREXIA 210 0.0006
539 CHILLS 71 0.0006
540 ORGANISING PNEUMONIA 3 0.0006
541 ACUTE CORONARY SYNDROME 5 0.0006
542 BLOOD PRESSURE DECREASED 40 0.0006
543 HEPATIC ENZYME ABNORMAL 3 0.0006
544 MOBILITY DECREASED 43 0.0006
545 BACK PAIN 139 0.0006
546 LEFT VENTRICULAR DYSFUNCTION 4 0.0006
547 CORONARY ARTERY STENOSIS 3 0.0006
548 MYALGIA 101 0.0006
549 SENSATION OF FOREIGN BODY 5 0.0006
550 LETHARGY 34 0.0006
551 ABDOMINAL DISTENSION 61 0.0006
552 WEIGHT DECREASED 163 0.0006
553 CONTUSION 56 0.0006
554 PARANOIA 10 0.0006
555 ADRENAL INSUFFICIENCY 7 0.0006
556 DELIRIUM 20 0.0006
557 HEART RATE IRREGULAR 13 0.0006
558 GAIT DISTURBANCE 110 0.0006
559 MASS 8 0.0006
560 HYPERSENSITIVITY 106 0.0006
561 JOINT DISLOCATION 6 0.0006
562 MIGRAINE 54 0.0006
563 SCIATICA 9 0.0006
564 ORAL HERPES 11 0.0006
565 ANGINA PECTORIS 16 0.0006
566 FAECES SOFT 4 0.0005
567 HEADACHE 342 0.0005
568 RETINAL DETACHMENT 5 0.0005
569 RESPIRATORY DISTRESS 15 0.0005
570 TREMOR 90 0.0005
571 CYSTIC FIBROSIS 3 0.0005
572 GASTRIC ULCER HAEMORRHAGE 3 0.0005
573 HEPATIC ENCEPHALOPATHY 5 0.0005
574 SKIN INFECTION 6 0.0005
575 NEURALGIA 13 0.0005
576 ACUTE PULMONARY OEDEMA 3 0.0005
577 OCULAR DISCOMFORT 6 0.0005
578 CYSTITIS 17 0.0005
579 URINARY TRACT INFECTION 91 0.0005
580 MITRAL VALVE INCOMPETENCE 6 0.0005
581 ANAEMIA 101 0.0005
582 MUSCULAR WEAKNESS 60 0.0005
583 CARDIAC VALVE DISEASE 3 0.0005
584 CARDIAC FAILURE CONGESTIVE 42 0.0005
585 TINNITUS 24 0.0005
586 MOUTH ULCERATION 11 0.0005
587 HYPOAESTHESIA 78 0.0005
588 CATARACT 31 0.0005
589 CHOLELITHIASIS 17 0.0005
590 THROAT TIGHTNESS 14 0.0005
591 ATRIOVENTRICULAR BLOCK 4 0.0005
592 FEELING HOT 31 0.0005
593 FALL 168 0.0005
594 NASAL DISCOMFORT 4 0.0005
595 PNEUMOTHORAX 8 0.0005
596 RENAL CYST 4 0.0005
597 POLYNEUROPATHY 6 0.0005
598 HYPOTONIA 5 0.0005
599 DIPLOPIA 13 0.0005
600 GASTROENTERITIS VIRAL 9 0.0005
601 MYASTHENIA GRAVIS 4 0.0005
602 PALPITATIONS 58 0.0005
603 ASTHENIA 186 0.0005
604 FOETAL GROWTH RESTRICTION 3 0.0005
605 BACK DISORDER 8 0.0005
606 DRY THROAT 5 0.0005
607 HYPERCALCAEMIA 6 0.0005
608 PERIPHERAL SWELLING 74 0.0005
609 DRUG DEPENDENCE 77 0.0005
610 PNEUMONITIS 13 0.0005
611 MALAISE 209 0.0005
612 URTICARIA 79 0.0005
613 DIVERTICULITIS 13 0.0005
614 RETCHING 10 0.0005
615 BODY HEIGHT DECREASED 5 0.0005
616 INFUSION SITE PAIN 6 0.0005
617 DISCOMFORT 28 0.0005
618 ASPERGILLUS INFECTION 3 0.0005
619 HYPOGAMMAGLOBULINAEMIA 3 0.0005
620 STAPHYLOCOCCAL INFECTION 15 0.0005
621 LYMPHOCYTE COUNT DECREASED 8 0.0005
622 FOOT DEFORMITY 5 0.0005
623 HAEMOGLOBIN DECREASED 46 0.0004
624 NEUROPATHY PERIPHERAL 42 0.0004
625 GASTROINTESTINAL CARCINOMA 4 0.0004
626 PSYCHOTIC DISORDER 13 0.0004
627 AGGRESSION 22 0.0004
628 RASH ERYTHEMATOUS 21 0.0004
629 CORONARY ARTERY OCCLUSION 6 0.0004
630 PNEUMONIA BACTERIAL 4 0.0004
631 FATIGUE 338 0.0004
632 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 78 0.0004
633 ORAL DISCOMFORT 6 0.0004
634 ATRIAL FIBRILLATION 42 0.0004
635 UNRESPONSIVE TO STIMULI 11 0.0004
636 LEUKAEMIA 4 0.0004
637 HAND FRACTURE 3 0.0004
638 CONSTIPATION 92 0.0004
639 FEAR OF INJECTION 3 0.0004
640 METASTASIS 3 0.0004
641 THYROID CANCER 5 0.0004
642 WRONG TECHNIQUE IN DRUG USAGE PROCESS 15 0.0004
643 MUSCLE SPASMS 75 0.0004
644 MUSCLE SPASTICITY 5 0.0004
645 INFLAMMATION 21 0.0004
646 GAMMA-GLUTAMYLTRANSFERASE INCREASED 9 0.0004
647 HYPOPHOSPHATAEMIA 3 0.0004
648 DRUG INTOLERANCE 39 0.0004
649 BLADDER DISORDER 4 0.0004
650 LACTIC ACIDOSIS 13 0.0004
651 INTENTIONAL PRODUCT USE ISSUE 35 0.0004
652 HYPERKALAEMIA 14 0.0004
653 DERMATITIS ALLERGIC 5 0.0004
654 COVID-19 69 0.0004
655 MATERNAL EXPOSURE DURING PREGNANCY 35 0.0004
656 DEVICE PHYSICAL PROPERTY ISSUE 3 0.0004
657 VIRAL INFECTION 13 0.0004
658 HYPONATRAEMIA 22 0.0004
659 PERICARDIAL EFFUSION 9 0.0004
660 THYROID DISORDER 6 0.0004
661 TENDONITIS 6 0.0004
662 VISUAL IMPAIRMENT 48 0.0004
663 SWOLLEN TONGUE 12 0.0004
664 PULMONARY HYPERTENSION 8 0.0004
665 CYANOSIS 6 0.0004
666 HEAD INJURY 12 0.0004
667 ULCER 6 0.0004
668 SENSORY DISTURBANCE 6 0.0004
669 LOCALISED INFECTION 9 0.0004
670 BLOOD BILIRUBIN INCREASED 10 0.0004
671 PHARYNGITIS STREPTOCOCCAL 4 0.0004
672 RASH PRURITIC 20 0.0004
673 ABNORMAL FAECES 3 0.0004
674 ABDOMINAL PAIN 85 0.0004
675 BLOOD CHOLESTEROL INCREASED 17 0.0004
676 RESPIRATORY ARREST 10 0.0004
677 INFUSION RELATED REACTION 24 0.0004
678 HEMIPLEGIA 3 0.0004
679 PRODUCT USE IN UNAPPROVED INDICATION 89 0.0004
680 ARRHYTHMIA 17 0.0004
681 WITHDRAWAL SYNDROME 15 0.0004
682 PRURITUS 137 0.0004
683 ADVERSE DRUG REACTION 32 0.0004
684 PANCREATITIS ACUTE 8 0.0004
685 ABDOMINAL PAIN UPPER 73 0.0004
686 PRODUCT DOSE OMISSION ISSUE 104 0.0004
687 NERVOUS SYSTEM DISORDER 11 0.0004
688 BLOOD PRESSURE ABNORMAL 7 0.0004
689 INJECTION SITE BRUISING 28 0.0004
690 HYPOGLYCAEMIA 17 0.0004
691 NEOPLASM 4 0.0003
692 BLOOD MAGNESIUM DECREASED 3 0.0003
693 DIZZINESS 173 0.0003
694 ORTHOSTATIC HYPOTENSION 6 0.0003
695 GRIP STRENGTH DECREASED 3 0.0003
696 LUNG INFILTRATION 3 0.0003
697 INFECTION 49 0.0003
698 BACTERAEMIA 4 0.0003
699 LOSS OF CONSCIOUSNESS 43 0.0003
700 HAEMORRHAGE 35 0.0003
701 FEAR 9 0.0003
702 HALLUCINATION 25 0.0003
703 THERAPEUTIC RESPONSE SHORTENED 11 0.0003
704 LEUKOCYTOSIS 6 0.0003
705 HERPES ZOSTER 19 0.0003
706 ECONOMIC PROBLEM 5 0.0003
707 EATING DISORDER 7 0.0003
708 EXOSTOSIS 3 0.0003
709 PAIN 200 0.0003
710 NERVE COMPRESSION 3 0.0003
711 MUSCULOSKELETAL PAIN 17 0.0003
712 TENDON RUPTURE 4 0.0003
713 DRUG EXPOSURE DURING PREGNANCY 11 0.0003
714 FEMUR FRACTURE 10 0.0003
715 CYST 4 0.0003
716 APPENDICITIS 3 0.0003
717 BLOOD SODIUM DECREASED 6 0.0003
718 ARTHRALGIA 132 0.0003
719 MUSCLE ATROPHY 4 0.0003
720 DYSPEPSIA 31 0.0003
721 STEVENS-JOHNSON SYNDROME 7 0.0003
722 INJECTION SITE SWELLING 24 0.0003
723 COLITIS ULCERATIVE 14 0.0003
724 POST PROCEDURAL COMPLICATION 6 0.0003
725 ABDOMINAL DISCOMFORT 52 0.0003
726 AUTOIMMUNE DISORDER 3 0.0003
727 RENAL FAILURE ACUTE 13 0.0003
728 NECK PAIN 17 0.0003
729 DISORIENTATION 12 0.0003
730 DEPRESSED MOOD 16 0.0003
731 DRUG INTERACTION 48 0.0003
732 DECREASED APPETITE 70 0.0003
733 COAGULOPATHY 5 0.0003
734 GAIT INABILITY 10 0.0003
735 APHASIA 9 0.0003
736 DRUG INEFFECTIVE 390 0.0003
737 ANGIOEDEMA 13 0.0003
738 ERYTHEMA 60 0.0003
739 HYPERBILIRUBINAEMIA 3 0.0003
740 SWELLING 27 0.0003
741 FEELING ABNORMAL 69 0.0003
742 NERVOUSNESS 15 0.0003
743 INJURY 20 0.0003
744 HEAD DISCOMFORT 5 0.0003
745 HEPATOCELLULAR INJURY 4 0.0003
746 EXTRAPYRAMIDAL DISORDER 7 0.0003
747 INTERNATIONAL NORMALISED RATIO INCREASED 8 0.0003
748 HOT FLUSH 21 0.0003
749 VISION BLURRED 38 0.0003
750 ANOSMIA 4 0.0003
751 TOOTHACHE 5 0.0003
752 C-REACTIVE PROTEIN INCREASED 10 0.0003
753 INTERVERTEBRAL DISC PROTRUSION 6 0.0003
754 INJECTION SITE PAIN 84 0.0003
755 HYPOPHAGIA 7 0.0003
756 RESTLESSNESS 10 0.0003
757 BLOOD GLUCOSE ABNORMAL 5 0.0003
758 DEVICE MALFUNCTION 19 0.0003
759 HAEMATOMA 7 0.0003
760 HEPATIC STEATOSIS 5 0.0003
761 MALNUTRITION 3 0.0003
762 EYE PRURITUS 9 0.0003
763 SPEECH DISORDER 14 0.0003
764 HEPATIC CIRRHOSIS 5 0.0003
765 GASTRITIS 7 0.0003
766 RHEUMATOID ARTHRITIS 30 0.0003
767 MYOCARDIAL ISCHAEMIA 3 0.0003
768 PRODUCT AVAILABILITY ISSUE 6 0.0003
769 GASTRIC ULCER 5 0.0003
770 CARDIO-RESPIRATORY ARREST 11 0.0003
771 INCORRECT DOSE ADMINISTERED 60 0.0003
772 MUSCULOSKELETAL DISORDER 5 0.0003
773 INTERNAL HAEMORRHAGE 3 0.0003
774 INSURANCE ISSUE 4 0.0003
775 WHITE BLOOD CELL COUNT INCREASED 10 0.0003
776 DRY EYE 13 0.0003
777 MUSCLE TWITCHING 6 0.0003
778 PHARYNGEAL OEDEMA 4 0.0003
779 AGITATION 19 0.0003
780 EXPOSURE DURING PREGNANCY 16 0.0003
781 KIDNEY INFECTION 5 0.0003
782 CARDIAC ARREST 21 0.0003
783 INJECTION SITE PRURITUS 17 0.0003
784 OCULAR HYPERAEMIA 12 0.0003
785 HAEMATOCRIT DECREASED 5 0.0003
786 PRODUCT PRESCRIBING ERROR 6 0.0003
787 MACULAR DEGENERATION 3 0.0003
788 HYPERLIPIDAEMIA 3 0.0003
789 UPPER LIMB FRACTURE 5 0.0003
790 INSOMNIA 66 0.0002
791 CONFUSIONAL STATE 40 0.0002
792 FLATULENCE 14 0.0002
793 BLOOD POTASSIUM INCREASED 4 0.0002
794 INTENTIONAL DOSE OMISSION 7 0.0002
795 CARDIOMEGALY 3 0.0002
796 GENERALISED OEDEMA 3 0.0002
797 BONE PAIN 14 0.0002
798 ABDOMINAL PAIN LOWER 6 0.0002
799 HAEMATEMESIS 6 0.0002
800 FLUID RETENTION 12 0.0002
801 COGNITIVE DISORDER 11 0.0002
802 CIRCULATORY COLLAPSE 4 0.0002
803 BLOOD POTASSIUM DECREASED 7 0.0002
804 ANAPHYLACTIC SHOCK 6 0.0002
805 METASTASES TO CENTRAL NERVOUS SYSTEM 3 0.0002
806 MUSCULOSKELETAL DISCOMFORT 4 0.0002
807 MENTAL DISORDER 10 0.0002
808 DEAFNESS 6 0.0002
809 HYPOTENSION 46 0.0002
810 EPILEPSY 7 0.0002
811 SOMNOLENCE 46 0.0002
812 BEDRIDDEN 3 0.0002
813 TOOTH DISORDER 5 0.0002
814 RASH MACULO-PAPULAR 5 0.0002
815 NEOPLASM MALIGNANT 15 0.0002
816 INCORRECT ROUTE OF DRUG ADMINISTRATION 8 0.0002
817 GLOSSODYNIA 5 0.0002
818 ORAL PAIN 5 0.0002
819 NAUSEA 176 0.0002
820 DRY MOUTH 18 0.0002
821 DYSPHAGIA 21 0.0002
822 ACUTE HEPATIC FAILURE 3 0.0002
823 BONE DISORDER 4 0.0002
824 NIGHT SWEATS 7 0.0002
825 FLUSHING 22 0.0002
826 RASH 94 0.0002
827 AMNESIA 14 0.0002
828 SWELLING FACE 14 0.0002
829 DIARRHOEA 137 0.0002
830 FOOT FRACTURE 4 0.0002
831 LIP SWELLING 7 0.0002
832 BLOOD CREATINE PHOSPHOKINASE INCREASED 6 0.0002
833 LOWER LIMB FRACTURE 4 0.0002
834 HYPERTHYROIDISM 3 0.0002
835 COMPLICATION ASSOCIATED WITH DEVICE 3 0.0002
836 SEPSIS 23 0.0002
837 HEPATIC ENZYME INCREASED 14 0.0002
838 ASCITES 6 0.0002
839 GASTRIC DISORDER 7 0.0002
840 ABASIA 5 0.0002
841 NIGHTMARE 7 0.0002
842 DEPRESSED LEVEL OF CONSCIOUSNESS 8 0.0002
843 INJECTION SITE ERYTHEMA 25 0.0002
844 PNEUMONIA ASPIRATION 5 0.0002
845 ABORTION SPONTANEOUS 8 0.0002
846 PREMATURE BABY 6 0.0002
847 HAEMATOCHEZIA 11 0.0002
848 VOMITING 93 0.0002
849 FEBRILE NEUTROPENIA 13 0.0002
850 HYPOKALAEMIA 9 0.0002
851 MYELOSUPPRESSION 7 0.0002
852 MUSCULOSKELETAL CHEST PAIN 3 0.0002
853 DELUSION 3 0.0002
854 DERMATITIS 4 0.0002
855 GASTROINTESTINAL DISORDER 17 0.0002
856 EYE SWELLING 7 0.0002
857 DRY SKIN 25 0.0002
858 EPISTAXIS 14 0.0002
859 INTERSTITIAL LUNG DISEASE 9 0.0002
860 POOR QUALITY SLEEP 4 0.0002
861 SKIN CANCER 4 0.0002
862 FAECES DISCOLOURED 4 0.0002
863 CLOSTRIDIUM DIFFICILE INFECTION 4 0.0002
864 IMPAIRED HEALING 6 0.0002
865 JOINT SWELLING 22 0.0002
866 MENTAL STATUS CHANGES 5 0.0002
867 DEATH 155 0.0002
868 SKIN DISORDER 6 0.0002
869 BLOOD UREA INCREASED 3 0.0002
870 DEMENTIA 5 0.0002
871 MULTIPLE ORGAN DYSFUNCTION SYNDROME 5 0.0002
872 SHOCK 4 0.0002
873 UNEVALUABLE EVENT 13 0.0002
874 METASTASES TO LIVER 3 0.0002
875 LYMPHADENOPATHY 6 0.0002
876 RHABDOMYOLYSIS 7 0.0002
877 IRRITABILITY 10 0.0002
878 ARTHRITIS 13 0.0002
879 END STAGE RENAL DISEASE 3 0.0002
880 HYPERHIDROSIS 21 0.0002
881 DRUG ADMINISTRATION ERROR 5 0.0002
882 ARTHROPATHY 9 0.0002
883 DYSGEUSIA 12 0.0002
884 BLOOD ALKALINE PHOSPHATASE INCREASED 4 0.0002
885 MEMORY IMPAIRMENT 22 0.0002
886 CEREBROVASCULAR ACCIDENT 27 0.0002
887 CARDIOVASCULAR DISORDER 4 0.0002
888 HEPATITIS 4 0.0002
889 HERNIA 3 0.0002
890 SKIN ULCER 4 0.0002
891 RENAL IMPAIRMENT 13 0.0002
892 DYSTONIA 3 0.0002
893 JOINT STIFFNESS 4 0.0002
894 SKIN DISCOLOURATION 7 0.0002
895 OSTEONECROSIS 5 0.0002
896 THROMBOCYTOPENIA 17 0.0002
897 ACTIVITIES OF DAILY LIVING IMPAIRED 3 0.0002
898 ASPARTATE AMINOTRANSFERASE INCREASED 8 0.0002
899 THERAPEUTIC RESPONSE DECREASED 9 0.0001
900 COMA 7 0.0001
901 INJECTION SITE WARMTH 3 0.0001
902 RENAL FAILURE 19 0.0001
903 KNEE ARTHROPLASTY 3 0.0001
904 PRODUCT DOSE OMISSION IN ERROR 4 0.0001
905 PLATELET COUNT DECREASED 15 0.0001
906 RECTAL HAEMORRHAGE 6 0.0001
907 HYPERSOMNIA 4 0.0001
908 ALTERED STATE OF CONSCIOUSNESS 3 0.0001
909 BLOOD GLUCOSE INCREASED 26 0.0001
910 ACUTE KIDNEY INJURY 21 0.0001
911 MELAENA 3 0.0001
912 DEHYDRATION 18 0.0001
913 THERAPEUTIC RESPONSE UNEXPECTED 6 0.0001
914 INTESTINAL OBSTRUCTION 5 0.0001
915 PANCREATITIS 7 0.0001
916 ILL-DEFINED DISORDER 8 0.0001
917 SKIN IRRITATION 6 0.0001
918 DISTURBANCE IN ATTENTION 7 0.0001
919 EMOTIONAL DISORDER 4 0.0001
920 BONE DENSITY DECREASED 4 0.0001
921 MENTAL IMPAIRMENT 3 0.0001
922 DYSKINESIA 5 0.0001
923 CEREBRAL INFARCTION 3 0.0001
924 NEUTROPHIL COUNT DECREASED 5 0.0001
925 CONVULSION 7 0.0001
926 OFF LABEL USE 107 0.0001
927 EYE IRRITATION 7 0.0001
928 VISUAL ACUITY REDUCED 4 0.0001
929 AGEUSIA 3 0.0001
930 GASTRIC CANCER 3 0.0001
931 EXPOSURE VIA SKIN CONTACT 3 0.0001
932 DEVICE DISLOCATION 5 0.0001
933 SEPTIC SHOCK 5 0.0001
934 RASH MACULAR 4 0.0001
935 ANHEDONIA 3 0.0001
936 ALANINE AMINOTRANSFERASE INCREASED 7 0.0001
937 SEIZURE 13 0.0001
938 CEREBRAL HAEMORRHAGE 4 0.0001
939 FREQUENT BOWEL MOVEMENTS 3 0.0001
940 TREATMENT NONCOMPLIANCE 6 0.0001
941 DEPENDENCE 6 0.0001
942 COMPLETED SUICIDE 9 0.0001
943 GASTROINTESTINAL HAEMORRHAGE 9 0.0001
944 PANCYTOPENIA 6 0.0001
945 ALOPECIA 21 0.0001
946 PAIN IN JAW 3 0.0001
947 INJECTION SITE REACTION 7 0.0001
948 CONTRAINDICATED PRODUCT ADMINISTERED 3 0.0001
949 DRUG-INDUCED LIVER INJURY 3 0.0001
950 NEUTROPENIA 13 0.0001
951 WHITE BLOOD CELL COUNT DECREASED 10 0.0001
952 EYE DISORDER 3 0.0001
953 LIVER DISORDER 4 0.0001
954 ANGER 3 0.0001
955 EYE PAIN 5 0.0001
956 SUICIDAL IDEATION 8 0.0001
957 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 4 0.0001
958 TREATMENT FAILURE 7 0.0001
959 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 6 0.0001
960 SKIN BURNING SENSATION 6 0.0001
961 NO ADVERSE EVENT 15 0.0001
962 CRYING 3 0.0001
963 STOMATITIS 5 0.0001
964 INJECTION SITE MASS 3 0.0001
965 LEUKOPENIA 4 0.0001
966 PRODUCT USE ISSUE 15 0.0001
967 MALIGNANT NEOPLASM PROGRESSION 8 0.0001
968 ABNORMAL BEHAVIOUR 3 0.0001
969 BRADYCARDIA 4 0.0001
970 EMOTIONAL DISTRESS 9 0.0001
971 BLINDNESS 3 0.0001
972 MULTIPLE SCLEROSIS RELAPSE 5 0.0001
973 UNDERDOSE 5 0.0001
974 SURGERY 4 0.0001
975 PRODUCT QUALITY ISSUE 9 0.0001
976 SUICIDE ATTEMPT 4 0.0001
977 VERTIGO 4 0.0001
978 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 11 0.0001
979 BREAST CANCER 5 0.0001
980 CHRONIC KIDNEY DISEASE 4 0.0001
981 DRUG DOSE OMISSION BY DEVICE 4 0.0001
982 BLADDER CANCER 3 0.0001
983 INJECTION SITE HAEMORRHAGE 4 0.0001
984 FOETAL EXPOSURE DURING PREGNANCY 4 0.0000
985 OVERDOSE 10 0.0000
986 DRUG WITHDRAWAL SYNDROME 4 0.0000
987 DRUG DOSE OMISSION 6 0.0000
988 TOXICITY TO VARIOUS AGENTS 6 0.0000
989 INTENTIONAL PRODUCT MISUSE 3 0.0000
990 PSORIASIS 4 0.0000
991 ACCIDENTAL EXPOSURE TO PRODUCT 3 0.0000
992 DISEASE PROGRESSION 3 0.0000